TP53 and hepatocellular carcinoma: In sum, we demonstrated that the aberrant expression of miR-221-3p and miR-375 may affect HBV-DNA replication, as well as the proliferation, migration, and invasion of HCC cells, possibly by modulating the expression of TP53. Thus, these two miRNAs may serve as crucial biomarkers for HCC diagnosis and prognosis.